News

Home-based spirometry — a test to measure how well the lungs are working — provides results that are almost as reliable as those taken in a hospital, and such testing could help people with cystic fibrosis (CF) monitor their condition without as many visits to the doctor, a study…

The Clairity Ball — the hallmark annual event of Claire’s Place Foundation — is set to return to Southern California later this month with an evening of fundraising that will bring together celebrities and champions of the cystic fibrosis (CF) community. The nonprofit’s May 31 ball, to…

Long-term Trikafta treatment led to improved lung function, fewer respiratory symptoms, and lower sweat chloride levels — elevated levels are a key hallmark of cystic fibrosis (CF) — in children with CF, ages 6 to 11, according to new findings from a two-year extension study. Trikafta was…

Regular exercise improves fitness in adults with cystic fibrosis (CF), and treatment with Kaftrio — a combination of elexacaftor, tezacaftor, and ivacaftor that’s marketed as Trikafta in the U.S. — may help patients engage more in higher-intensity physical activity, a German study suggests. The study, “Effects of…

The events slated for this year’s Cystic Fibrosis Awareness Month aim to celebrate the accomplishments, milestones, and hopes of those in the cystic fibrosis (CF) community. During May, U.S. and international organizations are encouraging people with CF to share their experiences and challenges, helping others picture what the future…

People with diabetes related to cystic fibrosis (CF) who had better long-term sugar control were more fit, a study found, suggesting that keeping blood sugar within normal limits may help improve the ability to exercise. The study, “The association between dysglycaemia and exercise capacity in cystic fibrosis,” was…

Treating expectant mothers with CFTR modulators may help to reduce the risk of intestinal complications for babies with cystic fibrosis (CF), according to a small real-world study from France. “We hope that such a study, merged with other international programmes, will also provide support for the European Medicines…

Children and adolescents with cystic fibrosis (CF) treated with Kaftrio, marketed as Trikafta in the U.S., experienced increases in the fat-soluble vitamins D and A for up to one year, according to a study from Spain. Treatment reduced the proportion of participants with vitamin D and vitamin A…

Kaftrio (elexacaftor/tezacaftor/ivacaftor), branded as Trikafta in the U.S., may help clear the nasal passages and surrounding air-filled cavities, known as sinuses, in children and adolescents with cystic fibrosis (CF), according to a real-world study from France. In the MODUL-CF study (NCT04301856), which involved 391 children and adolescents…

Undergraduate and graduate students in the U.S. who have cystic fibrosis (CF) are invited to apply for Abbvie‘s CF Scholarship program — the 2025 applications are now open, according to the pharmaceutical company’s website. Each year, the program selects 40 students for awards, with each given a…